Immune system discovery could revolutionize treatment for chronic disease and cancer
A discovery about the mechanisms that enable the immune system to sustain long-term protection could revolutionize treatment for chronic disease...
Treatment
Vigil’s TREM2-Targeted Alzheimer’s Treatment Shows Early Promise, Moves On to Phase II
In a possible redemption for the TREM2 space in Alzheimer’s disease, Vigil Neuroscience announced positive early-stage data Thursday for its...
Unique Immune Response in Lupus Paves Way for New Treatment | Newsroom
Immune cells called monocytes produce a key inflammatory protein called interleukin-1 beta (IL-1β) through an unconventional pathway in patients with...
